SMTL ID : 1fdt.1

HUMAN 17-BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE 1 COMPLEXED WITH ESTRADIOL AND NADP+

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

homo-dimer

Ligands

2 x SO4: SULFATE ION(Non-functional Binders)

SO4.1: 8 residues within 4Å: Chain A: G.145, L.146, F.160, E.163, R.266 Chain B: F.160, R.266 Ligands: SO4.4 3 PLIP interactions: 1 interactions with chain B, 2 interactions with chain A Salt bridges: B:R.266, A:R.266 Water bridges: A:R.266 SO4.4: 8 residues within 4Å: Chain A: F.160, R.266 Chain B: G.145, L.146, F.160, E.163, R.266 Ligands: SO4.1 4 PLIP interactions: 1 interactions with chain A, 3 interactions with chain B Salt bridges: A:R.266, B:R.266 Hydrogen bonds: B:E.163 Water bridges: B:R.266

2 x EST: ESTRADIOL(Non-covalent)

EST.2: 13 residues within 4Å: Chain A: S.142, V.143, L.149, Y.155, E.194, Y.218, H.221, S.222, F.226, F.259, M.279, E.282 Ligands: NAP.3 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:V.143, A:L.149, A:Y.155, A:E.194, A:F.226, A:F.226, A:F.259 Hydrogen bonds: A:S.142, A:E.282, A:E.282 EST.5: 13 residues within 4Å: Chain B: S.142, V.143, L.149, Y.155, E.194, Y.218, H.221, S.222, F.226, F.259, M.279, E.282 Ligands: NAP.6 10 PLIP interactions: 10 interactions with chain B Hydrophobic interactions: B:V.143, B:L.149, B:Y.155, B:E.194, B:F.226, B:F.226, B:F.259 Hydrogen bonds: B:S.142, B:Y.155, B:E.282

2 x NAP: NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Covalent)

NAP.3: 31 residues within 4Å: Chain A: G.9, C.10, S.11, S.12, G.13, I.14, G.15, L.16, T.35, L.36, R.37, D.38, T.41, L.64, D.65, V.66, R.67, N.90, A.91, G.92, L.93, T.140, G.141, S.142, Y.155, K.159, C.185, G.186, V.188, F.226 Ligands: EST.2 23 PLIP interactions: 23 interactions with chain A Hydrophobic interactions: A:V.188 Hydrogen bonds: A:G.9, A:G.9, A:G.9, A:S.11, A:S.12, A:S.12, A:I.14, A:G.15, A:L.16, A:R.37, A:R.37, A:R.37, A:D.38, A:D.65, A:V.66, A:N.90, A:A.91, A:G.92, A:Y.155, A:K.159, A:K.159, A:V.188 NAP.6: 31 residues within 4Å: Chain B: G.9, C.10, S.11, S.12, G.13, I.14, G.15, L.16, T.35, L.36, R.37, D.38, T.41, L.64, D.65, V.66, R.67, N.90, A.91, G.92, L.93, T.140, G.141, S.142, Y.155, K.159, C.185, G.186, V.188, F.226 Ligands: EST.5 23 PLIP interactions: 23 interactions with chain B Hydrophobic interactions: B:V.188 Hydrogen bonds: B:G.9, B:G.9, B:G.9, B:S.11, B:S.12, B:S.12, B:I.14, B:G.15, B:L.16, B:R.37, B:R.37, B:R.37, B:D.38, B:T.41, B:V.66, B:N.90, B:A.91, B:G.92, B:T.140, B:K.159, B:K.159, B:V.188

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Breton, R. et al., The structure of a complex of human 17beta-hydroxysteroid dehydrogenase with estradiol and NADP+ identifies two principal targets for the design of inhibitors. Structure (1996)

Release Date

1997-02-12

Peptides

17-BETA-HYDROXYSTEROID-DEHYDROGENASE: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

17-BETA-HYDROXYSTEROID-DEHYDROGENASE

Related Entries With Identical Sequence